灵芝孢子粉抗肿瘤活性的研究进展.PDFVIP

  • 13
  • 0
  • 约3.24万字
  • 约 4页
  • 2018-10-01 发布于天津
  • 举报
灵芝孢子粉抗肿瘤活性的研究进展

2015 1 37 1 Hebei Medical Journal ,2015 , 河北医药 年 月 第 卷 第 期 Vol 37 Jan No. 1 105 KATP-channels in the cardioprotection of preconditioning and postcondi- propofo1. Anaesthesia ,2008 ,63 :1046-1055. tioning by sevoflurane in the rat in vivo. Anesth Analg ,2005 ,101 :1252- 40 De Hert SG ,Van der Linden PJ ,Crombeecke S ,et al. Choice of primary 1260. anesthetic regimen can influence intensive care unit length of stay after 37 El Azab SR ,Rosseel PM ,De Lange JJ ,et al. Effect of sevoflurane on the coronary surgery with cardiopulmonary bypass. Anesthesiology ,2004 , ex vivo secretion of TNF-alpha during and after coronary artery bypass 101 :9-20. surgery. Eur J Anaesthesiol ,2003 ,20 :380-384. 41 Yu CH ,Beattie WS. The effects of volatile anesthetics on cardiac ische- 38 Conzen PF ,Fischer S ,Detter C ,et al. Sevoflurane provides greater pro- mic complications and mortality in CABG :a metaanalysis. Can J An- tection of the myocardium than propofol in patients undergoing off-pump aesth ,2006 ,53 :906-918. coronary artery bypass surgery. Anesthesiology ,2003 ,99 :826-833. 42 Preckel B ,Bolten J. Pharmacology of modern volatile anaesthetics. Best 39 Bein B ,Renner J ,Caliebe D ,et al. The effects of interrupted or continu- Pract Res Clin Anaesthesiol ,2005 ,19 :331-348. ous administration of sevoflurane on preconditioning before cardio-pul- ( 期:2014 - 08 - 17) 收稿日 monary bypass in coronary artery surgery :comparison with continuous doi :10. 3969 /j. issn. 1002 - 7386. 2015. 01. 039 · 讲座 · 综述与 灵芝孢子粉抗肿瘤活性的研究进展 王卫霄 吕艳茹 姚苗苗 张晓静 杜晓欣 赵素芬 【 】 ; 关

文档评论(0)

1亿VIP精品文档

相关文档